REDI-GRO CORPORATION – Trademark Portfolio

Entity Type: 03

REDI-GRO CORPORATION holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REDI-GRO. The owner is based in SACRAMENTO, CA.

8909 ELDER CREEK RD.

SACRAMENTO, CA 95828

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

REDI-GRO CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (6 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

31
Natural Agricultural Products (5 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does REDI-GRO CORPORATION have?

REDI-GRO CORPORATION has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 5 cancelled.

What trademark classes does REDI-GRO CORPORATION file in?

REDI-GRO CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 31 (Natural Agricultural Products). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are REDI-GRO CORPORATION's most well-known trademarks?

REDI-GRO CORPORATION's registered trademark portfolio includes well-known marks such as REDI-GRO. These are among 1 currently registered trademark in the portfolio.

What is REDI-GRO CORPORATION's trademark registration success rate?

REDI-GRO CORPORATION has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.